Paloma Partners’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-135,953
| Closed | -$428K | – | 2204 |
|
|
2020
Q3 | $428K | Buy |
+135,953
| New | +$428K | 0.01% | 1124 |
|
|
2020
Q1 | – | Sell |
-16,983
| Closed | -$55K | – | 2063 |
|
|
2019
Q4 | $55K | Sell |
16,983
-169,917
| -91% | -$550K | ﹤0.01% | 1775 |
|
|
2019
Q3 | $404K | Sell |
186,900
-14,347
| -7% | -$31K | 0.01% | 1040 |
|
|
2019
Q2 | $632K | Buy |
+201,247
| New | +$632K | 0.01% | 730 |
|
|
2019
Q1 | – | Sell |
-48,600
| Closed | -$141K | – | 1677 |
|
|
2018
Q4 | $141K | Sell |
48,600
-155,300
| -76% | -$451K | ﹤0.01% | 854 |
|
|
2018
Q3 | $536K | Buy |
+203,900
| New | +$536K | 0.01% | 742 |
|
|
2018
Q2 | – | Sell |
-19,068
| Closed | -$56K | – | 1874 |
|
|
2018
Q1 | $56K | Sell |
19,068
-59,326
| -76% | -$174K | ﹤0.01% | 1353 |
|
|
2017
Q4 | $215K | Buy |
78,394
+47,239
| +152% | +$130K | ﹤0.01% | 1104 |
|
|
2017
Q3 | $106K | Buy |
31,155
+255
| +0.8% | +$868 | ﹤0.01% | 1432 |
|
|
2017
Q2 | $76K | Buy |
+30,900
| New | +$76K | ﹤0.01% | 1579 |
|
|
2016
Q2 | – | Sell |
-79,533
| Closed | -$265K | – | 2018 |
|
|
2016
Q1 | $265K | Buy |
+79,533
| New | +$265K | ﹤0.01% | 1200 |
|
|
2013
Q4 | – | Sell |
-22,900
| Closed | -$183K | – | 1360 |
|
|
2013
Q3 | $183K | Sell |
22,900
-1,296
| -5% | -$10.4K | 0.01% | 747 |
|
|
2013
Q2 | $187K | Buy |
+24,196
| New | +$187K | 0.01% | 930 |
|